chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Arthralgia, Balance disorder, Chills, Confusional state
Clinical narrative: very hard to breath; 42 days interval from the first shot; extreme dizziness; extreme looseness; sweating a lot; confusion over 5 weeks; sweating a lot; it got worst a really bad reaction; horrific joint pain; fever 100.1 degrees Fahrenheit; nauseous; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness) and the first episode of HYPERHIDROSIS (sweating a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), the first episode of HYPERHIDROSIS (sweating a lot), CONFUSIONAL STATE (confusion over 5 weeks), the second episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (very hard to breath), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), CONFUSIONAL STATE (confusion over 5 weeks), the last episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot) had resolved.            Patient went to ER but they did not do anything.The patient is allergic to other things, not taking any vitamins and doesn't want to provide her medications. no treatment and concomitant medications were reported  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-186627 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Hyperhidrosis, Inappropriate schedule of product administration, Nausea
Clinical narrative: very hard to breath; 42 days interval from the first shot; extreme dizziness; extreme looseness; sweating a lot; confusion over 5 weeks; sweating a lot; it got worst a really bad reaction; horrific joint pain; fever 100.1 degrees Fahrenheit; nauseous; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness) and the first episode of HYPERHIDROSIS (sweating a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), the first episode of HYPERHIDROSIS (sweating a lot), CONFUSIONAL STATE (confusion over 5 weeks), the second episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (very hard to breath), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), CONFUSIONAL STATE (confusion over 5 weeks), the last episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot) had resolved.            Patient went to ER but they did not do anything.The patient is allergic to other things, not taking any vitamins and doesn't want to provide her medications. no treatment and concomitant medications were reported  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-186627 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: very hard to breath; 42 days interval from the first shot; extreme dizziness; extreme looseness; sweating a lot; confusion over 5 weeks; sweating a lot; it got worst a really bad reaction; horrific joint pain; fever 100.1 degrees Fahrenheit; nauseous; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness) and the first episode of HYPERHIDROSIS (sweating a lot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021, the patient experienced DYSPNOEA (very hard to breath), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), the first episode of HYPERHIDROSIS (sweating a lot), CONFUSIONAL STATE (confusion over 5 weeks), the second episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (very hard to breath), DIZZINESS (extreme dizziness), BALANCE DISORDER (extreme looseness), CONFUSIONAL STATE (confusion over 5 weeks), the last episode of HYPERHIDROSIS (sweating a lot), ADVERSE REACTION (it got worst a really bad reaction), ARTHRALGIA (horrific joint pain), PYREXIA (fever 100.1 degrees Fahrenheit), NAUSEA (nauseous) and CHILLS (chills) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (42 days interval from the first shot) had resolved.            Patient went to ER but they did not do anything.The patient is allergic to other things, not taking any vitamins and doesn't want to provide her medications. no treatment and concomitant medications were reported  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-186627 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Dyspnoea, Insomnia, Memory impairment
Clinical narrative: Difficulty breathing; Forgetfulness; Anxiety; Insomnia; Chest pain; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (Difficulty breathing), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety), INSOMNIA (Insomnia) and CHEST PAIN (Chest pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety), INSOMNIA (Insomnia) and CHEST PAIN (Chest pain). At the time of the report, DYSPNOEA (Difficulty breathing), MEMORY IMPAIRMENT (Forgetfulness), ANXIETY (Anxiety), INSOMNIA (Insomnia) and CHEST PAIN (Chest pain) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: have many allergies; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (have many allergies) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (have many allergies). At the time of the report, ALLERGY TO VACCINE (have many allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: heart palpitations; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart palpitations). At the time of the report, PALPITATIONS (heart palpitations) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Sciatica, Varicose vein
Clinical narrative: varicose veins in the left leg; I've had problems with sciatic nerve in my left hip; This spontaneous case was reported by a health care professional and describes the occurrence of SCIATICA (I've had problems with sciatic nerve in my left hip) and VARICOSE VEIN (varicose veins in the left leg) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced SCIATICA (I've had problems with sciatic nerve in my left hip). On an unknown date, the patient experienced VARICOSE VEIN (varicose veins in the left leg). At the time of the report, SCIATICA (I've had problems with sciatic nerve in my left hip) and VARICOSE VEIN (varicose veins in the left leg) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included generic of Flonase for sinuses, vitamin C and vitamin D for unknown indications.  Patient reported that she had sciatic nerve in her left hip after second vaccination. But, she stated that normally she had it in her right hip and it was strange to notice it her left hip. She also mentioned that she has Varicose vein in her left leg and had reported about that to her primary care physician. Patient said that she visited another doctor on 16 Mar 2021 for the same, but he had prescribed her with Prednisone but she didn't wanted to take it because she had it before and it had given her insomnia. She also stated that no treatment was taken for Sciatic nerve pain incident.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Gait disturbance, Mobility decreased
Clinical narrative: Hard time walking; problems with mobility; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Hard time walking) and MOBILITY DECREASED (problems with mobility) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced GAIT DISTURBANCE (Hard time walking) and MOBILITY DECREASED (problems with mobility). At the time of the report, GAIT DISTURBANCE (Hard time walking) and MOBILITY DECREASED (problems with mobility) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided.  Concomitant medications was not given.
Sex: U
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: shaking after second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking after second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TREMOR (shaking after second shot). At the time of the report, TREMOR (shaking after second shot) outcome was unknown.            No concomitant medication was reported. No treatment was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       AE submitted via chatbot. no concomitant medications and treatment medications was provided.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Laryngitis, Swelling
Clinical narrative: battling acute laryngitis; experiencing swelling; This spontaneous case was reported by a patient and describes the occurrence of LARYNGITIS (battling acute laryngitis) and SWELLING (experiencing swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LARYNGITIS (battling acute laryngitis) and SWELLING (experiencing swelling). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, LARYNGITIS (battling acute laryngitis) and SWELLING (experiencing swelling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            Concomitant product use was not provided. No treatment was reported. Action taken in response to mRNA-1273 was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Coughing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Coughing). At the time of the report, COUGH (Coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported ,   No treatment medication was reported .
Sex: U
Vaccine: COVID19
Symptoms: Feeling cold, Myalgia
Clinical narrative: I am verycold; Muscles hurt; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (I am verycold) and MYALGIA (Muscles hurt) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING COLD (I am verycold) and MYALGIA (Muscles hurt). At the time of the report, FEELING COLD (I am verycold) and MYALGIA (Muscles hurt) outcome was unknown.            Patient reported that he was very cold and Got second shot yesterday.  Patient was very cold and muscles hurt.  Asked whether normal.  Concomitant medications were not provided.  Treatment medications was not given.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Recurring vaccine side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (Recurring vaccine side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included no.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Recurring vaccine side effects). At the time of the report, VACCINATION COMPLICATION (Recurring vaccine side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: fully vacillating since February. I got Covid.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (fully vacillating since February. I got Covid.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (fully vacillating since February. I got Covid.). At the time of the report, COVID-19 (fully vacillating since February. I got Covid.) outcome was unknown.            Concomitant product was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph node swollen in your arm pit; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node swollen in your arm pit) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node swollen in your arm pit). At the time of the report, LYMPHADENOPATHY (Lymph node swollen in your arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I had my 2 vaccines 7 weeks apart; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I had my 2 vaccines 7 weeks apart) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I had my 2 vaccines 7 weeks apart). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I had my 2 vaccines 7 weeks apart) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal pain upper
Clinical narrative: Abdominal pain; Stomach ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain) and ABDOMINAL PAIN UPPER (Stomach ache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain) and ABDOMINAL PAIN UPPER (Stomach ache). At the time of the report, ABDOMINAL PAIN (Abdominal pain) and ABDOMINAL PAIN UPPER (Stomach ache) outcome was unknown.            The concomitant medication was not provided.  The treatment information was not provided.  The action item  with mRNA 1273 with the events was considered as not applicable.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported   Reporter did not allow further contact
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chest discomfort, Pyrexia, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026B21A) for COVID-19 immunization. No medical history reported. On Apr 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever). At the time of the report,  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) outcome: unknown. Diagnostic results: On an unknown date, body temperature:  Low-grade fever (low). No concomitant medication or treatment information reported. Patient took second dose on May 27, 2021. Action taken with mRNA-1273 in response to the events: not applicable. This case linked to MOD-2021-186718 (patient link).
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026B21A) for COVID-19 immunization. No medical history reported. On Apr 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever). At the time of the report,  chest discomfort (tightness in upper chest), vaccination site pain (injection arm sore) and pyrexia (low-grade fever) outcome: unknown. Diagnostic results: On an unknown date, body temperature:  Low-grade fever (low). No concomitant medication or treatment information reported. Patient took second dose on May 27, 2021. Action taken with mRNA-1273 in response to the events: not applicable. This case linked to MOD-2021-186718 (patient link).
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chest discomfort, Pyrexia, Vaccination site pain
Clinical narrative: tightness in upper chest; chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain). At the time of the report, CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-186664 (Patient Link).
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain
Clinical narrative: tightness in upper chest; chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain). At the time of the report, CHEST DISCOMFORT (tightness in upper chest) and CHEST PAIN (chest pain) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-186664 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: leg cramps; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (leg cramps) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (leg cramps). At the time of the report, MUSCLE SPASMS (leg cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: I'm having squeezing chest pains; This spontaneous case was reported by a patient and describes the occurrence of CHEST PAIN (I'm having squeezing chest pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced CHEST PAIN (I'm having squeezing chest pains). At the time of the report, CHEST PAIN (I'm having squeezing chest pains) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ORAL CONTRACEPTIVE NOS for Contraception.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details was not reported by the reporter.    This case was linked to MOD-2021-187207 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache, Throat irritation
Clinical narrative: Throat is itchy after the vaccine; Really bad headache after the vaccine/temple hurts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts). At the time of the report, THROAT IRRITATION (Throat is itchy after the vaccine) and HEADACHE (Really bad headache after the vaccine/temple hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Muscle aches; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle aches), HEADACHE (headache) and PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscle aches), HEADACHE (headache) and PYREXIA (fever). At the time of the report, MYALGIA (Muscle aches), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.            Concomitant medications details were not reported by the reporter. No treatment information provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient presented for second dose of the vaccine passed 42 days.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient presented for second dose of the vaccine passed 42 days.) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient presented for second dose of the vaccine passed 42 days.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient presented for second dose of the vaccine passed 42 days.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature decreased, Intentional product use issue, Vaccination site rash
Clinical narrative: Temperature dropped to 94 degrees Celsius; not taking the 2nd dose because of the side effects; Little red rash on site of Injection; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE DECREASED (Temperature dropped to 94 degrees Celsius), INTENTIONAL PRODUCT USE ISSUE (not taking the 2nd dose because of the side effects) and VACCINATION SITE RASH (Little red rash on site of Injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BODY TEMPERATURE DECREASED (Temperature dropped to 94 degrees Celsius), INTENTIONAL PRODUCT USE ISSUE (not taking the 2nd dose because of the side effects) and VACCINATION SITE RASH (Little red rash on site of Injection). The patient was treated with Manual therapy (Rubbing alcohol) for Body temperature decreased and Manual therapy (Rubbing alcohol) for Vaccination site rash. At the time of the report, BODY TEMPERATURE DECREASED (Temperature dropped to 94 degrees Celsius) and VACCINATION SITE RASH (Little red rash on site of Injection) had resolved and INTENTIONAL PRODUCT USE ISSUE (not taking the 2nd dose because of the side effects) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 94 (Low) Temperature dropped to 94 degrees.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medication reported. No treatment was provided.    Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-Up received contains No new Information On 26-Jul-2021: Significant follow up received included information about outcome of the events, new event added and action taken with suspect product was updated.
Sex: U
Vaccine: COVID19
Symptoms: Cough, Nasal congestion
Clinical narrative: congested; coughing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congested) and COUGH (coughing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (congested) and COUGH (coughing). At the time of the report, NASAL CONGESTION (congested) and COUGH (coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Neuralgia
Clinical narrative: My nerves were on fire and still bug me; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (My nerves were on fire and still bug me) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEURALGIA (My nerves were on fire and still bug me). At the time of the report, NEURALGIA (My nerves were on fire and still bug me) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details was reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sick with the first dose; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (sick with the first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick with the first dose). At the time of the report, ILLNESS (sick with the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Headache, Swelling, Tenderness
Clinical narrative: my shoulder was really swollen/ small golf ball on my shoulder; had redness for about 6-7 days; tender; very slight headache; This spontaneous case was reported by a patient and describes the occurrence of SWELLING (my shoulder was really swollen/ small golf ball on my shoulder), ERYTHEMA (had redness for about 6-7 days), TENDERNESS (tender) and HEADACHE (very slight headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (my shoulder was really swollen/ small golf ball on my shoulder), ERYTHEMA (had redness for about 6-7 days), TENDERNESS (tender) and HEADACHE (very slight headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, SWELLING (my shoulder was really swollen/ small golf ball on my shoulder), ERYTHEMA (had redness for about 6-7 days), TENDERNESS (tender) and HEADACHE (very slight headache) outcome was unknown.            Concomitant medications details were not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: pain in thigh bones; pain in my left hip; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in thiGH bones) and ARTHRALGIA (pain in my left hip) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in thiGH bones) and ARTHRALGIA (pain in my left hip). At the time of the report, PAIN IN EXTREMITY (pain in thiGH bones) and ARTHRALGIA (pain in my left hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache
Clinical narrative: Fatigue; Joint Pain; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and HEADACHE (Headache). At the time of the report, FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.